What is the recommended management of a molar pregnancy?

Molar Pregnancy Management

Suction curettage is the definitive method for evacuating a molar pregnancy, followed by mandatory registration with a specialized gestational trophoblastic disease (GTD) center for serial hCG monitoring to detect progression to gestational trophoblastic neoplasia (GTN). 1, 2

Immediate Management: Uterine Evacuation

Surgical Approach

• Suction curettage is the method of choice for both complete and partial molar pregnancies 2
• Avoid medical evacuation methods (misoprostol, mifepristone) for complete moles—this increases the risk of GTN by 16-fold compared to surgical removal 2
• For partial moles, medical evacuation may be acceptable only when large fetal parts prevent suction curettage 2
• Consider ultrasound guidance during the procedure to minimize perforation risk and ensure complete evacuation 2
• Have blood products available pre-operatively due to potential significant hemorrhage 1
• Administer anti-D immunoglobulin to Rh-negative women 2

Alternative Options

• Hysterectomy may be considered for older women who have completed childbearing, particularly those with complete moles 1
• Hysteroscopic resection is emerging as a feasible alternative but remains investigational and is not standard practice 3

Critical Post-Evacuation Surveillance

hCG Monitoring Protocol

The surveillance strategy differs based on molar type:

For Complete Hydatidiform Mole (CHM):

• Measure serum hCG at least every 2 weeks until normalization 1
• After normalization, continue monthly hCG monitoring for up to 6 months 1
• Use the same hCG assay type throughout, ideally as advised by the GTD center 1

For Partial Hydatidiform Mole (PHM):

• Monitor hCG every 2 weeks until normal 1
• Require one additional confirmatory normal hCG value over 1 month after initial normalization 1
• Then discharge from monitoring 1

Diagnosis of GTN

GTN is diagnosed when hCG demonstrates:

• Plateauing over 3 consecutive values measured 1 week apart, OR
• Rising over 2 consecutive values measured 1 week apart (FIGO criteria) 1

This diagnosis does not require histological confirmation 2

Registration with GTD Centers

All patients must be registered with a specialized GTD center—this represents the minimum standard of care 2. The UK experience demonstrates cure rates of 98-100% with this centralized approach 2. These centers provide:

• Expert hCG monitoring and interpretation
• Early detection of GTN (13-16% risk after complete mole, 0.5-1.0% after partial mole) 2
• Specialized nursing support and counseling
• Management of false-positive hCG results

Contraception During Follow-Up

Hormonal contraception is recommended during the entire hCG monitoring period to:

• Maintain reliability of hCG as a tumor marker 4
• Prevent confusion from pregnancy-related hCG elevation
• Combined oral contraceptives are preferred unless contraindicated 1

Contraception should continue until hCG monitoring is complete.

Common Pitfalls to Avoid

False-Positive hCG Results

If hCG remains persistently low and unexplained:

• Check urine hCG—if negative with positive serum, suspect assay interference (human anti-mouse antibodies) 1
• Consider pituitary hCG in perimenopausal women
• Exclude renal failure, germ cell tumors, and familial hCG syndromes 1
• Reference laboratories can perform dilution testing or blocking agent tests 1

Imaging Considerations

• Ultrasound correctly identifies only 56-88% of molar pregnancies pre-evacuation 2
• Many molar pregnancies appear as "missed miscarriage" or "anembryonic pregnancy" on early ultrasound 2
• Definitive diagnosis requires histopathological examination with p57 immunohistochemistry and ploidy analysis to distinguish complete from partial moles 2

Prognosis and Future Fertility

• Cure rates approach 100% with appropriate management 2, 5
• Subsequent pregnancy outcomes are comparable to the general population 4
• Risk of recurrent molar pregnancy is 1-2% in subsequent pregnancies 4
• Psychosocial support should be offered to all patients given the significant emotional impact 4

The key to optimal outcomes is the combination of appropriate initial surgical management, meticulous hCG surveillance through specialized centers, and timely identification of GTN requiring chemotherapy.